MELD-Na > 16 is associated with high peri-procedural and short-term mortality in patients with ruptured hepatocellular carcinoma treated with emergent transarterial embolization.
Michael C JundtRobert L OwenScott M ThompsonChad J FlemingAndrew H StocklandJames C AndrewsPublished in: Abdominal radiology (New York) (2021)
MELD-Na > 16 is associated with very high peri-procedural (67% at 30 days) and short-term (89% at 90 days) mortality in patients with ruptured HCC treated with emergent transarterial embolization. A better understanding of these prognostic factors may help guide treatment decisions and provide realistic expectations when counseling patients and their families.
Keyphrases
- prognostic factors
- newly diagnosed
- end stage renal disease
- cardiovascular events
- ejection fraction
- chronic kidney disease
- subarachnoid hemorrhage
- risk factors
- cardiovascular disease
- human immunodeficiency virus
- radiofrequency ablation
- endovascular treatment
- patient reported outcomes
- peritoneal dialysis
- men who have sex with men
- replacement therapy
- patient reported